糖尿病中的心脏能量代谢:新兴的治疗点和临床影响
Archee Panwar1, Sufyan O Malik1, Muhtasim Adib1
1Cardiovascular Research Centre, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
概括
糖尿病心肌病源于心脏代谢的改变,有利于脂肪酸而不是葡萄糖的氧化. 针对心脏能量代谢,为糖尿病心力衰竭提供了有希望的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 代谢障碍 代谢障碍 代谢障碍
- 生物化学 生物化学
背景情况:
- 糖尿病显著增加了糖尿病心肌病和心血管并发症的风险.
- 关键的病理变化包括线粒体脂肪酸氧化增加和糖尿病心脏中葡萄糖氧化减少.
- 这种代谢转变会损害心脏效率,增加氧化应激,促进脂毒性,并导致心脏功能障碍.
研究的目的:
- 审查心脏能量代谢改变在糖尿病引起的心脏功能障碍中的作用.
- 探索针对糖尿病心血管疾病的心脏代谢的当前和潜在的治疗策略.
主要方法:
- 对糖尿病中心脏代谢研究的文献综述.
- 分析代谢变化对心脏功能的影响.
- 对影响心脏能量通路的现有和新兴治疗剂的评估.
主要成果:
- 改变心脏能量代谢,以转向脂肪酸氧化为特征,是糖尿病心脏病的重要因素.
- 现有的治疗方法,如GLP-1受体激动剂和SGLT2抑制剂,可以通过调节心脏代谢来发挥益处.
- 直接针对心脏脂肪酸或葡萄糖氧化是一种有希望的治疗途径.
结论:
- 失调的心脏能量代谢是糖尿病患者心力衰竭的关键驱动因素.
- 旨在使心脏新陈代谢正常化的治疗干预措施具有治疗糖尿病引起的心血管并发症的巨大潜力.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Overview of Carbohydrate Metabolism
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.


